Fairvalue-Calculator Fairvalue-Calculator
EN DE

SKAN Group (SKAN) Fair Value & Analysis

Healthcare · CH · Market cap CHF 1.1B

PriceCHF 48.95
Fair ValueCHF 15.92
Upside-67.5%
Quality89/100
Evidence: Medium Range CHF 11.80 – CHF 19.91

Fair value as of: Jun 24, 2026

Analysis

SKAN Group (SKAN) currently trades at CHF 48.95, while our model-based Fair Value estimate is CHF 15.92 — implying the stock looks roughly 67.5% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard. It also provides digital solutions, lifecycle support, laboratory services, and SKAN labs. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is SKAN Group (SKAN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of CHF 15.92 versus a price of CHF 48.95 — about −67% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SKAN?
Our 21-model fair value for SKAN Group is CHF 15.92 (as of Jun 24, 2026), built from audited fundamentals. The current price is CHF 48.95.
What is the quality score of SKAN?
SKAN Group has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.